- Headquarters
- Stanford, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- linkcelltx.com
- Total Funding
- $72.0M
- Last Round
- $60.0M Series ADec 2025
- Rounds
- 2
About
Developing logic-gate CAR T cell therapies for solid tumors, founded by Stanford researchers in partnership with Samsara BioCapital.
Summary
Link Cell Therapies is a Biotech company based in Stanford, United States. It has raised $72.0M in total across 2 rounds, most recently a $60.0M Series A round in Dec 2025. Investors include Johnson & Johnson Innovation and Samsara BioCapital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Dec 2025
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...
Clinical-stage biopharmaceutical company founded in 2015 developing best-in-class cancer therapeu...
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/link-cell-therapies"><img src="https://indexed.vc/api/badge/company/link-cell-therapies" alt="Link Cell Therapies on Indexed.vc" width="260" height="76" /></a>